6 UNITED STATES DISTRICT COURT 7 WESTERN DISTRICT OF WASHINGTON 8 AT SEATTLE
9 CHRISTOPHER A. SHAFER, Case No. C20-1056RSM 10
11 Plaintiff, ORDER DENYING MOTION TO EXCLUDE OR LIMIT OPINIONS OF 12 v. ROBERT ALLEN, M.D. AND DENYING 13 MOTIONS FOR LEAVE TO RESPOND C.R. BARD, INC. and BARD PERIPHERAL 14 VASCULAR, INC.,
15 Defendants. 16 This matter comes before the Court on Defendants C.R. Bard, Inc. and Bard Peripheral 17 Vascular, Inc.’s Motion to Exclude or Otherwise Limit Improper Opinions from Robert Allen, 18 19 M.D., Dkt. #30, and two Motions from Plaintiff seeking leave to file a late response brief to that 20 Motion, Dkts. #37 and #40. 21 Plaintiff has failed to demonstrate good cause to extend the time for filing a response 22 brief under Rule 6(b)(1). Plaintiff’s counsel states he mis-calendared this deadline due in part to 23 the large number of similar cases he is handling. See Dkt. #40 at 4 (“Since Defendants’ Daubert 24 25 Motion was served, counsel for Plaintiff has responded to more than thirty motions for 26 summary judgment and Daubert motions in cases involving Bard in federal courts around the 27 country. In this case, the error was the result of a lapse in counsel’s calendaring processes…”). 28 This does not demonstrate excusable neglect or good cause for granting the requested relief, 1 2 rather it reflects a predictable consequence of taking on too many similar cases. Furthermore, 3 given the proximity to trial, permitting a late response would necessitate reply briefing and 4 likely cause some prejudice to counsel. These Motions will therefore be denied. 5 The Court will thus rule on the underlying issue based solely on the materials submitted 6 by Defendants. The Court will not interpret Plaintiff’s failure to file a timely response as an 7 8 admission of the merits of Defendants’ Motion. 9 The background facts of this case are adequately summarized by Defendants: 10 Plaintiff Christopher A. Shafer was treated with a Bard Recovery 11 inferior vena cava filter (“Recovery Filter”)—a prescription medical device placed in his inferior vena cava (“IVC”), the largest 12 vein in the body that returns blood from the lower extremities to 13 the heart—to prevent pulmonary embolism. He brings this product liability action, alleging that Bard is strictly liable for defects in 14 warning and design of the Recovery Filter. In support of his claims, Plaintiff disclosed case-specific expert Dr. Robert Allen, 15 and Bard subsequently deposed Dr. Allen. 16 DKt. #30 at 1. 17 Federal Rule of Evidence 702 provides that a witness who is qualified as an expert by 18 19 knowledge, skill, experience, training, or education may testify in the form of an opinion or 20 otherwise if: 21 (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of 22 fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; 23 (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case. 24
25 Under Rule 702, the trial court acts as a gatekeeper and ensures that the proffered 26 scientific testimony meets certain standards of both relevance and reliability before it is 27 admitted. Daubert v. Merrell Dow Pharm., Inc. ("Daubert I"), 509 U.S. 579, 590, 113 S. Ct. 28 2786, 125 L. Ed. 2d 469 (1993). The party proffering expert testimony has the burden of 1 2 showing the admissibility of the testimony by a preponderance of the evidence. Daubert I, 509 3 U.S. at 592 n.10. “[J]udges are entitled to broad discretion when discharging their gatekeeping 4 function” related to the admission of expert testimony. United States v. Hankey, 203 F.3d 1160, 5 1168 (9th Cir. 2000) (citing Kumho Tire Co. v. Carmichael, 526 U.S. 137, 150-53, 119 S. Ct. 6 1167, 143 L. Ed. 2d 238 (1999)). The Court considers four factors to determine if expert 7 8 testimony will assist the trier of fact: “(i) whether the expert is qualified; (ii) whether the subject 9 matter of the testimony is proper for the jury’s consideration; (iii) whether the testimony 10 conforms to a generally accepted explanatory theory; and (iv) whether the probative value of the 11 testimony outweighs its prejudicial effect.” Scott v. Ross, 140 F.3d 1275, 1285-86 (9th Cir. 12 13 1998). 14 As an initial matter, this Court must determine whether the proffered witness is qualified 15 as an expert by “knowledge, skill, experience, training or education.” Fed. R. Evid. 702. 16 Because the Rule “contemplates a broad conception of expert qualifications,” only a “minimal 17 foundation of knowledge, skill, and experience” is required. Hangarter v. Provident Life & 18 19 Accident Ins. Co., 373 F.3d 998, 1015-16 (9th Cir. 2004) (emphasis in original) (quoting 20 Thomas v. Newton Int’l Enters., 42 F.3d 1266, 1269 (9th Cir. 1994)). A “lack of particularized 21 expertise goes to the weight of [the] testimony, not its admissibility.” United States v. Garcia, 7 22 F.3d 885, 890 (9th Cir. 1993) (citing United States v. Little, 753 F.2d 1420, 1445 (9th Cir. 23 1984)); Daubert v. Merrell Dow Pharm., Inc. (“Daubert II”), 43 F.3d 1311, 1315 (9th Cir. 24 25 1995). 26 The trial court must also ensure that the proffered expert testimony is reliable. 27 Generally, to satisfy Rule 702’s reliability requirement, “the party presenting the expert must 28 show that the expert’s findings are based on sound science, and this will require some objective, 1 2 independent validation of the expert’s methodology.” Daubert II, 43 F.3d at 1316. Toward this 3 end, the Supreme Court in Daubert I set forth the following factors for the trial court to consider 4 when assessing the reliability of proffered expert testimony: (1) whether the expert’s method, 5 theory, or technique is generally accepted within the relevant scientific community; (2) whether 6 the method, theory, or technique can be (and has been) tested; (3) whether the method, theory, 7 8 or technique has been subjected to peer review and publication; and (4) the known or potential 9 rate of error of the method, theory, or technique. Daubert I, 509 U.S. at 593-94. An expert 10 opinion is reliable if it is based on proper methods and procedures rather than “subjective belief 11 or unsupported speculation.” Id. at 590. The test for reliability “‘is not the correctness of the 12 13 expert’s conclusions but the soundness of his methodology.’” Stilwell v. Smith & Nephew, Inc., 14 482 F.3d 1187, 1192 (9th Cir. 2007) (quoting Daubert II, 43 F.3d at 1318). 15 Alternative or opposing opinions or tests do not “preclude the admission of the expert’s 16 testimony – they go to the weight, not the admissibility.” Kennedy v. Collagen Corp., 161 F.3d 17 1226, 1231 (9th Cir. 1998).
Free access — add to your briefcase to read the full text and ask questions with AI
6 UNITED STATES DISTRICT COURT 7 WESTERN DISTRICT OF WASHINGTON 8 AT SEATTLE
9 CHRISTOPHER A. SHAFER, Case No. C20-1056RSM 10
11 Plaintiff, ORDER DENYING MOTION TO EXCLUDE OR LIMIT OPINIONS OF 12 v. ROBERT ALLEN, M.D. AND DENYING 13 MOTIONS FOR LEAVE TO RESPOND C.R. BARD, INC. and BARD PERIPHERAL 14 VASCULAR, INC.,
15 Defendants. 16 This matter comes before the Court on Defendants C.R. Bard, Inc. and Bard Peripheral 17 Vascular, Inc.’s Motion to Exclude or Otherwise Limit Improper Opinions from Robert Allen, 18 19 M.D., Dkt. #30, and two Motions from Plaintiff seeking leave to file a late response brief to that 20 Motion, Dkts. #37 and #40. 21 Plaintiff has failed to demonstrate good cause to extend the time for filing a response 22 brief under Rule 6(b)(1). Plaintiff’s counsel states he mis-calendared this deadline due in part to 23 the large number of similar cases he is handling. See Dkt. #40 at 4 (“Since Defendants’ Daubert 24 25 Motion was served, counsel for Plaintiff has responded to more than thirty motions for 26 summary judgment and Daubert motions in cases involving Bard in federal courts around the 27 country. In this case, the error was the result of a lapse in counsel’s calendaring processes…”). 28 This does not demonstrate excusable neglect or good cause for granting the requested relief, 1 2 rather it reflects a predictable consequence of taking on too many similar cases. Furthermore, 3 given the proximity to trial, permitting a late response would necessitate reply briefing and 4 likely cause some prejudice to counsel. These Motions will therefore be denied. 5 The Court will thus rule on the underlying issue based solely on the materials submitted 6 by Defendants. The Court will not interpret Plaintiff’s failure to file a timely response as an 7 8 admission of the merits of Defendants’ Motion. 9 The background facts of this case are adequately summarized by Defendants: 10 Plaintiff Christopher A. Shafer was treated with a Bard Recovery 11 inferior vena cava filter (“Recovery Filter”)—a prescription medical device placed in his inferior vena cava (“IVC”), the largest 12 vein in the body that returns blood from the lower extremities to 13 the heart—to prevent pulmonary embolism. He brings this product liability action, alleging that Bard is strictly liable for defects in 14 warning and design of the Recovery Filter. In support of his claims, Plaintiff disclosed case-specific expert Dr. Robert Allen, 15 and Bard subsequently deposed Dr. Allen. 16 DKt. #30 at 1. 17 Federal Rule of Evidence 702 provides that a witness who is qualified as an expert by 18 19 knowledge, skill, experience, training, or education may testify in the form of an opinion or 20 otherwise if: 21 (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of 22 fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; 23 (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case. 24
25 Under Rule 702, the trial court acts as a gatekeeper and ensures that the proffered 26 scientific testimony meets certain standards of both relevance and reliability before it is 27 admitted. Daubert v. Merrell Dow Pharm., Inc. ("Daubert I"), 509 U.S. 579, 590, 113 S. Ct. 28 2786, 125 L. Ed. 2d 469 (1993). The party proffering expert testimony has the burden of 1 2 showing the admissibility of the testimony by a preponderance of the evidence. Daubert I, 509 3 U.S. at 592 n.10. “[J]udges are entitled to broad discretion when discharging their gatekeeping 4 function” related to the admission of expert testimony. United States v. Hankey, 203 F.3d 1160, 5 1168 (9th Cir. 2000) (citing Kumho Tire Co. v. Carmichael, 526 U.S. 137, 150-53, 119 S. Ct. 6 1167, 143 L. Ed. 2d 238 (1999)). The Court considers four factors to determine if expert 7 8 testimony will assist the trier of fact: “(i) whether the expert is qualified; (ii) whether the subject 9 matter of the testimony is proper for the jury’s consideration; (iii) whether the testimony 10 conforms to a generally accepted explanatory theory; and (iv) whether the probative value of the 11 testimony outweighs its prejudicial effect.” Scott v. Ross, 140 F.3d 1275, 1285-86 (9th Cir. 12 13 1998). 14 As an initial matter, this Court must determine whether the proffered witness is qualified 15 as an expert by “knowledge, skill, experience, training or education.” Fed. R. Evid. 702. 16 Because the Rule “contemplates a broad conception of expert qualifications,” only a “minimal 17 foundation of knowledge, skill, and experience” is required. Hangarter v. Provident Life & 18 19 Accident Ins. Co., 373 F.3d 998, 1015-16 (9th Cir. 2004) (emphasis in original) (quoting 20 Thomas v. Newton Int’l Enters., 42 F.3d 1266, 1269 (9th Cir. 1994)). A “lack of particularized 21 expertise goes to the weight of [the] testimony, not its admissibility.” United States v. Garcia, 7 22 F.3d 885, 890 (9th Cir. 1993) (citing United States v. Little, 753 F.2d 1420, 1445 (9th Cir. 23 1984)); Daubert v. Merrell Dow Pharm., Inc. (“Daubert II”), 43 F.3d 1311, 1315 (9th Cir. 24 25 1995). 26 The trial court must also ensure that the proffered expert testimony is reliable. 27 Generally, to satisfy Rule 702’s reliability requirement, “the party presenting the expert must 28 show that the expert’s findings are based on sound science, and this will require some objective, 1 2 independent validation of the expert’s methodology.” Daubert II, 43 F.3d at 1316. Toward this 3 end, the Supreme Court in Daubert I set forth the following factors for the trial court to consider 4 when assessing the reliability of proffered expert testimony: (1) whether the expert’s method, 5 theory, or technique is generally accepted within the relevant scientific community; (2) whether 6 the method, theory, or technique can be (and has been) tested; (3) whether the method, theory, 7 8 or technique has been subjected to peer review and publication; and (4) the known or potential 9 rate of error of the method, theory, or technique. Daubert I, 509 U.S. at 593-94. An expert 10 opinion is reliable if it is based on proper methods and procedures rather than “subjective belief 11 or unsupported speculation.” Id. at 590. The test for reliability “‘is not the correctness of the 12 13 expert’s conclusions but the soundness of his methodology.’” Stilwell v. Smith & Nephew, Inc., 14 482 F.3d 1187, 1192 (9th Cir. 2007) (quoting Daubert II, 43 F.3d at 1318). 15 Alternative or opposing opinions or tests do not “preclude the admission of the expert’s 16 testimony – they go to the weight, not the admissibility.” Kennedy v. Collagen Corp., 161 F.3d 17 1226, 1231 (9th Cir. 1998). Furthermore, “‘[d]isputes as to the strength of [an expert’s] 18 19 credentials, faults in his use of [a particular] methodology, or lack of textual authority for his 20 opinion, go to the weight, not the admissibility, of his testimony.’” Id. (quoting McCullock v. 21 H.B. Fuller Co., 61 F.3d 1038, 1044 (2d Cir. 1995)). 22 Finally, the Court must ensure that the proffered expert testimony is relevant. As 23 articulated in Rule 702, expert testimony is relevant if it assists the trier of fact in understanding 24 25 evidence or in determining a fact in issue. Daubert I, 509 U.S. at 591. Thus, the party 26 proffering such evidence must demonstrate a valid scientific connection, or “fit,” between the 27 evidence and an issue in the case. Id. Expert testimony is inadmissible if it concerns factual 28 issues within the knowledge and experience of ordinary lay people because it would not assist 1 2 the trier of fact in analyzing the evidence. In the Ninth Circuit, “[t]he general test regarding the 3 admissibility of expert testimony is whether the jury can receive ‘appreciable help’ from such 4 testimony.” United States v. Gwaltney, 790 F.2d 1378, 1381 (9th Cir. 1986). Because 5 unreliable and unfairly prejudicial expert witness testimony is not helpful to the trier of fact, the 6 trial court should exclude such evidence. Jinro Am., Inc. v. Secure Invs., Inc., 266 F.3d 993, 7 8 1004 (9th Cir. 2001). Likewise, expert testimony that merely tells the jury what result to reach 9 is inadmissible. Fed. R. Evid. 704, Advisory Committee Note (1972); see, e.g., United States v. 10 Duncan, 42 F.3d 97, 101 (2d Cir. 1994) (“When an expert undertakes to tell the jury what result 11 to reach, this does not aid the jury in making a decision, but rather attempts to substitute the 12 13 expert’s judgment for the jury’s.”). 14 After reviewing the submitted materials, the Court finds Dr. Allen qualified to opine on 15 the adequacy of the warnings in the Instructions for Use (“IFU”) for the filter in question. 16 Defendants argue this witness “is not a warnings expert,” has never written an IFU for a 17 medical device, and has never worked for the FDA. Dkt. #30 at 8. However, Defendants admit 18 19 he is an experienced radiologist, and “may be qualified to opine about the information 20 physicians expect when making decisions about the use of IVC filters and whether that 21 information was in the Recovery Filter’s IFU.” Id. at 9. Because Rule 702 contemplates a 22 broad conception of expert qualifications, only a minimal foundation of knowledge, skill, and 23 experience” is required. Hangarter, supra. The Court’s review of the attached exhibits 24 25 demonstrates this witness has the necessary foundation as to this issue. Furthermore, 26 Defendants are splitting hairs as to the particularized expertise required for an expert to opine on 27 this issue, and a lack of particularized expertise goes to the weight of the testimony, not its 28 admissibility. Defendants are more than free to attack Dr. Allen’s qualifications on cross- 1 2 examination. 3 The Court finds Dr. Allen qualified to offer opinions on a possible design defect or 4 whether such a defect caused Plaintiff’s injuries. Defendants argue this witness “is not an 5 expert in IVC filter design, and his CV does not establish that he has ever designed an IVC 6 filter.” Dkt. #30 at 10. It is not clear to the Court that Dr. Allen intends to testify outside his 7 8 area of expertise, and he is permitted to testify as to what a doctor would expect from this 9 medical device and how this device interacted with a patient such as he would treat within his 10 practice. He is not qualified to testify as to the engineering of the product. Further 11 disagreement as to this issue can be addressed through objections at trial. 12 13 Defendants argue that Dr. Allen’s opinions on safer alternative filters suffer from 14 unreliable methodology. As an initial matter, although the Court acts as a gatekeeper here, it 15 will not question whether an allegedly safer alternative filter with a different course of 16 treatment—multiple implant procedures instead of one—was a viable alternative design at the 17 time of implementation. This is venturing too far into the factual weeds. Assuming that Dr. 18 19 Allen’s testimony as to a safer alternative filter has at least some merit, Defendants ask the 20 Court to find that this opinion was not based on reliable methodology because Dr. Allen “relied 21 on his ‘own experience and review of the medical literature and Bard’s internal documents, 22 along with the reports of Dr. McMeeking and others.” Dkt. #30 at 12–13. Defendants point out 23 that Dr. Allen cannot support his opinion with citation to articles published after the filter in 24 25 question was manufactured. However, Defendants do not adequately explain why Dr. Allen, 26 relying on his own experience, medical literature other than those articles, Defendant’s internal 27 documents, and the reports of Dr. McMeeking cannot opine on this issue. Dr. Allen is not 28 basing his opinion solely on subjective belief or unsupported speculation, and the review of 1 2 Defendants’ internal documents and the reports of Dr. McMeeking appear to be a sound 3 methodology for developing this opinion. This will not serve as a basis to exclude opinion 4 testimony. Defendants are more than free to attack Dr. Allen’s opinion on cross-examination. 5 Finally, the Court disagrees that Dr. Allen has failed to reliably apply a differential 6 diagnosis in concluding that Defendants’ filter caused Plaintiff’s injury. “A medical opinion on 7 8 causation that is based on a reliable differential diagnosis is admissible under Daubert.” 9 Luttrell v. Novartis Pharms. Corp., 894 F. Supp. 2d 1324, 1338 (E.D. Wash. 2012), aff'd, 555 F. 10 App’x 710 (9th Cir. 2014). But, to conduct a reliable differential diagnosis, “the expert must 11 explain why alternative hypotheses as to causation are ruled out using scientific methods and 12 13 procedures.” Id. Defendants argue, “[i]n his report, Dr. Allen, a medical expert, appears to 14 apply a differential diagnosis to the complications experienced by the subject filter, but not any 15 medical injuries allegedly attributable to the filter…. The next step in the causation chain— 16 connecting any complication experienced by the Recovery Filter to Plaintiff’s alleged injuries— 17 is where Dr. Allen… falls short.” Dkt. #30 at 15. The Court finds that Dr. Allen’s report, 18 19 submitted by Defendants, adequately explains why alternative hypotheses are ruled out using 20 valid scientific methodology, based on his experience and review of relevant medical records, 21 articles, and reports related to this and related litigation. Defendants’ concerns with the 22 weaknesses of Dr. Allen’s opinions on causation go to the weight of the testimony, not its 23 admissibility. 24 25 Given all of the above, the Court finds no basis to exclude any of Dr. Allen’s expert 26 opinions. Having reviewed the above Motions and the remainder of the record, the Court 27 hereby finds and ORDERS: 28 1) Plaintiffs’ Motions seeing leave to file a late response brief to that Motion, Dkts. #37 1 2 and #40, are DENIED. 3 2) Defendants’ Motion to Exclude or Otherwise Limit Improper Opinions from Robert 4 Allen, M.D., Dkt. #30, is DENIED. 5 DATED this 22nd day of September, 2021. 6
7 A 8 9 RICARDO S. MARTINEZ 10 CHIEF UNITED STATES DISTRICT JUDGE
12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28